Morepen Laboratories Ltd - 500288 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Morepen Laboratories Ltd has informed BSE regarding Issuance of Duplicate Share Certificates of the Company.22-10-2019
22-10-2019
Morepen Laboratories moves NCLT against Wockhardt to recover outstanding dues
Morepen is trying to recover around Rs 1.55 crore, along with interest, from Wockhardt on account of the bills it raised between July 2018 and May 2019 for the medicines it supplied to the company.22-10-2019
MOREPEN LABORATORIES LTD. - 500288 - Certificate Under Regulation 40 (10) Of The SEBI (LODR) Regulations, 2015
Please find enclosed herewith Certificate pursuant to Regulation 40 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.21-10-2019
Morepen Laboratories Ltd - 500288 - Shareholding for the Period Ended September 30, 2019
Morepen Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2019. For more details, kindly Click here16-10-2019
MOREPEN LABORATORIES LTD. - 500288 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Morepen Laboratories Ltd has informed BSE regarding Loss of Share Certificates of the Company.15-10-2019
Morepen Labs adds three new drugs - Rivaroxaban, Vildagliptin and UDCA
New drugs used for cardiac, diabetes and liver ailment segments will be added to its API portfolio14-10-2019
MOREPEN LABORATORIES LTD. - 500288 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release with the title ''Morepen Labs adds three new drugs - Rivaroxaban, Vildagliptin and UDCA to its API portfolio.''14-10-2019
Morepen Laboratories Ltd - 500288 - Compliance Certificate Under Regulation 7(3) Of The SEBI(LODR)Reg.,2015 For The Half Year Ended 30.09.2019.
Please find attached Compliance Certificate under Regulation 7(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended for the half year ended 30th September, 2019.11-10-2019
MOREPEN LABORATORIES LTD. - 500288 - Statement Of Investor Complaints For The Quarter Ended September 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0321 Name of the Signatory :- VIPUL KUMAR SRIVASTAVADesignation :- Company Secretary and Compliance Officer10-10-2019
Morepen Laboratories Ltd - 500288 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Morepen Laboratories Ltd has informed BSE regarding Issuance of Duplicate Share Certificates of the Company.10-10-2019